Humoral and Cellular Immunogenicity of Six Different Vaccines against SARS-CoV-2 in Adults: A Comparative Study in Tunisia (North Africa)

Background: The mass vaccination campaign against SARS-CoV-2 was started in Tunisia on 13 March 2021 by using progressively seven different vaccines approved for emergency use. Herein, we aimed to evaluate the humoral and cellular immunity in subjects aged 40 years and over who received one of the f...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben Ahmed, Melika, Bellali, Hedia, Gdoura, Mariem, Zamali, Imen, Kallala, Ouafa, Ben Hmid, Ahlem, Hamdi, Walid, Ayari, Hela, Fares, Hajer, Mechri, Karim, Marzouki, Soumaya, Triki, Henda, Ben Alaya, Nissaf, Chahed, Mohamed Kouni, Klouz, Anis, Sebai Ben Amor, Sonia, Ben Rayana, Chiheb, Razgallah Khrouf, Myriam, Hamouda, Chokri, Elkadri, Noomene, Daghfous, Riadh, Trabelsi, Abdelhalim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332781/
https://www.ncbi.nlm.nih.gov/pubmed/35893838
http://dx.doi.org/10.3390/vaccines10081189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332781/
https://www.ncbi.nlm.nih.gov/pubmed/35893838
http://dx.doi.org/10.3390/vaccines10081189

Ejemplares similares